Science

The data is in: COVID-19 vaccines are proving crucial in curbing the pandemic by slashing infections, hospitalizations, and deaths

A frontline healthcare worker receives a Moderna COVID-19 vaccination. Photo by William Campbell/Getty Images The coronavirus vaccines being rolled out are really, really good. The first real-world data shows huge drops in transmission, infections, and hospitalizations. Vaccines are more than a tool in the pandemic — they're our way out. Visit the Business section of Insider for more stories. For coronavirus vaccines, the good news keeps on coming.Scientists tracking the performance of sho...
Tags: Health, UK, Science, Scotland, Israel, US, Trends, Bloomberg, South Africa, Healthcare, Brazil, Astrazeneca, Pfizer, Bloomberg News, The Food and Drug Administration, Chris Jackson

The data is in: COVID-19 vaccines are proving to be crucial in curbing the pandemic by slashing infections, hospitalizations, and deaths

A frontline healthcare worker receives a Moderna COVID-19 vaccination. Photo by William Campbell/Getty Images The coronavirus vaccines being rolled out are really, really good.  The first real-world data shows huge drops in transmission, infections, and hospitalizations. Vaccines are more than a silver lining to the pandemic — they're our way out. Visit the Business section of Insider for more stories. For coronavirus vaccines, the good news keeps on coming.Scientists tracking the performa...
Tags: Health, UK, Science, Scotland, Israel, US, Trends, Bloomberg, South Africa, Healthcare, Brazil, Astrazeneca, Fda, Pfizer, Bloomberg News, Chris Jackson

With J&J's vaccine, the US will have enough coronavirus shots for every adult in May, Biden says. Here's your vaccination timeline.

A trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine. Janssen The US has authorized three coronavirus vaccines: from Johnson & Johnson, Moderna, and Pfizer. With the doses from J&J, the US could finish vaccinating priority groups in March. The US could distribute 500 million doses by the end of May — enough to vaccinate all of its adult population. Visit the Business section of Insider for more stories. A shot for every American. Political leaders a...
Tags: Usa, Science, News, Cdc, US, Trends, Merck, Joe Biden, UPS, House, Healthcare, Food And Drug Administration, Fda, Pfizer, Biden, Disneyland

People who've had COVID-19 might only need one vaccine jab - and saving shots on them could free up millions of doses for others

Justin Tallis - Pool / Getty Images Some experts believe people who have had COVID-19 should get just one shot of two-dose coronavirus vaccines. This would give these people protection while freeing up vaccine doses for others, they say. However, other experts warn the approach could be logistically difficult and scientifically "risky."  Visit the Business section of Insider for more stories. Experts are divided on whether people who have already had COVID-19 need a full coronavirus vacci...
Tags: UK, Science, London, Nbc, Maryland, France, US, Trends, Joe Biden, Analysis, Healthcare, Astrazeneca, Pfizer, Vaccine, Oxford University, Vaccines

Novavax's COVID-19 vaccine could be authorized as early as May, its CEO said. A trial suggests it is 89% effective, though slightly less so against contagious variants.

A volunteer receiving an injection for a vaccine against COVID-19 in South Africa. Felix Dlangamandla/Beeld/Gallo Images via Getty Images Novavax CEO Stanley Erck predicted his company's vaccine could be authorized in the US in May. He said the timing depended on whether the FDA would act largely based on UK trial data. Late-stage UK trials suggest the vaccine is highly effective, though a bit less so against variants. Visit the Business section of Insider for more stories. Novavax CEO Sta...
Tags: UK, New York, Science, Australia, US, Trends, Canada, South Africa, Healthcare, World Health Organization, Fda, Pfizer, Vaccine, Cnbc, US Food and Drug Administration, EUA

Why Johnson & Johnson's COVID-19 vaccine is probably the best shot

Business Insider A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine. Janssen Pfizer's and Moderna's COVID-19 vaccines were near perfect at preventing symptomatic infections in trials. Johnson & Johnson's shot has benefits: It's cheap, easy, and mild, and it performs against variants. The truth is you can't pick out which vaccine you get anyway, so it's a good thing they all work. Visit the Business section of Insider for more st...
Tags: Science, US, Trends, Public Health, South Africa, Healthcare, Fda, Pfizer, Johnson, Anthony Fauci, Boston Massachusetts, Johnson & Johnson, US Food and Drug Administration, New England Journal of Medicine, J J, Rubin

Spotlight on coronavirus vaccines overshadows furious effort to find new treatments

Might protection from COVID-19 be found in drugs as simple as pseudoephedrine and arthritis medication? Flaxseed and turmeric extract? Fish oil, ibuprofen, nasal spray, Vitamin D? Hopes are high that therapeutics might be hiding in plain sight in the medicine cabinet, but evidence remains sparse as research continues. One year into the pandemic, the U.S. Food and Drug Administration has approved just one drug to treat COVID-19, and its effects are modest. A few others, which mimic the work of na...
Tags: Science, News, Stanford, Senate, Israel, Sport, Ap, Public Health, Soccer, Healthcare, San Diego, World Health Organization, National Institutes of Health, Fda, Lausd, Khan

The US just authorized a 3rd coronavirus shot, adding a convenient, single-dose option to boost the rollout

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images The FDA just authorized Johnson & Johnson's single-dose coronavirus vaccine. The decision comes after a panel of independent experts voted unanimously on Friday in favor of recommending the shot.  J&J has said it will be ship nearly 4 million doses immediately following a regulatory OK.  Visit the Business...
Tags: Health, Science, News, US, Trends, Healthcare, Fda, Pfizer, Centers For Disease Control And Prevention, Johnson & Johnson, J J, Breaking, Moderna, Andrew Dunn, Coronavirus, COVID

J&J's one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images A panel of independent experts voted unanimously Friday in favor of recommending Johnson & Johnson's coronavirus vaccine.  US regulators are expected to authorize the single-dose vaccine in the coming days.  J&J has said it will be able to ship nearly 4 million doses following a regulatory OK.  Visit the B...
Tags: Health, Science, US, Trends, Healthcare, Fda, Pfizer, Johnson & Johnson, US Food and Drug Administration, EUA, Centers for Disease Control and Prevention Read, Moderna, Eric Rubin, Coronavirus, COVID, Coronavirus Vaccine

People who had COVID-19 develop strong immunity after a single vaccine dose - so they might need only one shot

A dentist receives the Moderna COVID-19 vaccine on January 8. mark Rightmire/Getty Images Two new studies suggest that people who had COVID-19 mount a stronger immune response to their first shot than those who were never infected. Other preliminary studies found that people who already had the coronavirus respond to their first shot the way other people do to their second. So it's possible some people might need only one shot to sufficiently protect them. Visit Business Insider's homepage...
Tags: UK, Science, News, Cdc, US, Los Angeles, Trends, Healthcare, Pfizer, The New York Times, Disneyland, Times, Antibodies, Centers For Disease Control And Prevention, Mount Sinai, Lax

A panel of scientists and doctors is reviewing J&J's one-dose coronavirus vaccine today. Here's what to watch for and how to follow along.

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images Johnson & Johnson's single-dose COVID-19 vaccine will face a crucial review Friday from an expert panel convened by the FDA. The meeting, scheduled for 9:00 a.m. ET to 5:30 p.m. ET, is expected to ultimately put J&J's shot one step closer to a regulatory OK. The FDA is live-streaming the all-day meeting on...
Tags: Health, Science, Youtube, US, Trends, Healthcare, Fda, Pfizer, Johnson & Johnson, US Food and Drug Administration, EUA, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine

Pfizer's COVID-19 vaccine performs just as well in the real world as it did in trials, a landmark Israeli study of more than 1 million people suggests. It was 94% effective.

Rabbi Yisrael Meir Lau receives a COVID-19 coronavirus vaccine at the Ichilov Hospital in Tel Aviv, Israel, Sunday, December 20, 2020. Ariel Schalit/AP Photo Pfizer-BioNTech's two-dose coronavirus vaccine was 94% effective at protecting against COVID-19 in a real-world study. In late-stage clinical trials before it was authorized, it was 95% effective. The new Israeli study of the Pfizer vaccine involved more than 1 million people. Visit the Business section of Insider for more stories. P...
Tags: Health, UK, Science, Israel, US, Trends, Harvard University, Healthcare, Sydney, Pfizer, Centers For Disease Control And Prevention, University of New South Wales, New England Journal of Medicine, Tel Aviv Israel, Johns Hopkins University, Ben Gurion University of the Negev

A coronavirus variant identified in California seems more infectious and deadly, a study found, with cases thought to be doubling every 18 days - but the scale of the threat is unclear

Pam Rasmussen, a principal, taking the temperature of arriving students during summer-school sessions in Monterey Park, California, on July 9. FREDERIC J. BROWN/AFP via Getty Images A study suggests a coronavirus variant first found in California is more contagious and deadly. The early study, first reported by Science, hasn't been formally scrutinized in a peer review. Some experts say more data is needed before the strain is considered especially dangerous. Visit the Business section of ...
Tags: Health, UK, Science, California, Boston, US, Trends, Taiwan, South Africa, New York Times, Healthcare, The New York Times, University Of California, Madison, Los Angeles Times, University Of Wisconsin

A coronavirus variant identified in California is more infectious, more deadly, and cases are doubling every 18 days, a study suggests - but the scale of the threat is unclear

Principal Pam Rasmussen (L) takes the temperature of arriving students as per coronavirus guidelines during summer school sessions in Monterey Park, California on July 9, 2020. FREDERIC J. BROWN/AFP via Getty Images A coronavirus variant first found in California is more contagious and deadlier than the original strain, an early study suggests. The study, first reported by Science, hasn't been formally scrutinized by other experts in a peer review. Some experts say more data is needed befo...
Tags: Health, UK, Science, California, Boston, US, Trends, Taiwan, South Africa, New York Times, Healthcare, The New York Times, UCSF, University of Wisconsin Madison, LA Times, Harvard T H Chan School of Public Health

The more data we get, the more it seems vaccinated people aren't spreading the coronavirus

A man receives a COVID-19 vaccine at a health services center in Rehovot, Israel, on January 14, 2021. Xinhua/Gil Cohen Magen via Getty Images COVID-19 vaccines can help reduce coronavirus transmission, preliminary research shows. Multiple studies show vaccinated people have lower viral loads, which are linked to less spread. Research suggests vaccines also reduce asymptomatic infections.  Visit the Business section of Insider for more stories. Now that effective coronavirus vaccines are a...
Tags: Health, UK, Science, News, Kentucky, Israel, US, Tel Aviv, Trends, Research, Healthcare, Oxford, Fda, Pfizer, London Underground, Anthony Fauci

FDA releases new data on J&J's single-dose coronavirus vaccine showing it's safe and effective

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images US regulators just released detailed data on Johnson & Johnson's coronavirus vaccine. The single-dose vaccine will be reviewed on Friday by an expert panel that advises the FDA. If OK'd, J&J will ship nearly 4 million doses immediately, and plans to deliver 100 million doses by the end of June. Visit the B...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Latin America, Johnson & Johnson, J J, Breaking, Moderna

FDA releases new data on J&J's single-dose coronavirus vaccine, says it is safe and effective

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images US regulators just released detailed data on Johnson & Johnson's coronavirus vaccine. The single-dose vaccine will be reviewed on Friday by an expert panel that advises the FDA. If OK'd, J&J will ship nearly 4 million doses immediately, and plans to deliver 100 million doses by the end of June. Visit the B...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Food And Drug Administration, Fda, Pfizer, Latin America, Johnson & Johnson, Novavax, Breaking, Moderna, Andrew Dunn

One simple chart shows how well J&J's single-dose coronavirus vaccine works, with protection starting after 2 weeks

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images A third US-authorized coronavirus vaccine is closer than ever.  Johnson & Johnson's single-dose shot was safe and effective at preventing COVID-19, US regulators said. One chart from the FDA's review shows how well the vaccine works, with protection coming after two weeks. Visit the Business section of Ins...
Tags: Health, Science, US, Trends, Getty Images, Healthcare, Food And Drug Administration, Fda, Pfizer, Johnson & Johnson, J J, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine

Scotland's vaccine rollout suggests delaying the 2nd COVID-19 shot is a bad idea

A frontline healthcare worker receives a Moderna COVID-19 vaccination at the Park County Health Departments storefront clinic on January 5, 2021 in Livingston, Montana. Photo by William Campbell/Getty Images The UK strategy to delay the second coronavirus vaccine dose for up to 12 weeks carries real risk. New data from Scotland showed protection against hospitalization peaking after five weeks — and then declining. Vaccine developers and public-health experts told Insider it's a mistake to...
Tags: Health, UK, Science, News, Obama, Scotland, Israel, Trends, Healthcare, Astrazeneca, Philadelphia, Pfizer, Children s Hospital, Patel, Paul Offit, Livingston Montana

A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro

A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world UK data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro

The coronavirus variant found in South Africa has been detected in a New York resident for the first time. 10 states have reported cases so far.

New York Gov. Andrew Cuomo. Lev Radin/Pacific Press/LightRocket via Getty The coronavirus variant first found in South Africa has been detected in a New York resident, Gov. Cuomo said Sunday. The variant, called B.1.351, has spread to 36 countries, and 10 states in the US. The variant from South Africa may be able to evade vaccines, studies suggest. Visit the Business section of Insider for more stories. The coronavirus variant found in South Africa has been confirmed in a New York residen...
Tags: Health, New York, Texas, Science, California, Cdc, New York City, US, Trends, South Africa, Connecticut, Healthcare, Astrazeneca, Novartis, Pfizer, Nassau County

Promising new data shows Pfizer's vaccine can overcome its ultra-cold storage requirements, as new research hints at just how effective the shot is

Pfizer announced Friday that they are seeking approval from the FDA to store its COVID-19 vaccine at higher temperatures. Dado Ruvic/Reuters Pfizer is seeking approval from the FDA to store COVID-19 vaccines at higher temperatures. Pfizer released data that shows the shots can be stored at temperatures between -13°F to 5°F. New research has also found the two-dose shot to be highly effective after one dose. Visit the Business section of Insider for more stories. Pfizer and BioNTech announc...
Tags: Health, Science, Cdc, Israel, US, Trends, Healthcare, Fda, Pfizer, Anthony Fauci, Centers For Disease Control And Prevention, Johnson Johnson, US Food and Drug Administration, Moderna, BioNtech, Albert Bourla

Pfizer-BioNTech's COVID-19 vaccine produces a much weaker immune response against the variant found in South Africa, a new study suggests

Margaret Keenan, 90, the first patient in the United Kingdom to receive the Pfizer/BioNtech covid-19 vaccine, speaks with Healthcare assistant Lorraine Hill as she prepares to leave University Hospital Coventry & Warwickshire, the day after receiving the first of two doses of the vaccine, on December 9, 2020 in Coventry, United Kingdom. The UK is the first country in the world to start vaccinating people with the Pfizer/BioNTech jab. Jonny Weeks/The Guardian - Pool/Getty Images Pfizer-BioN...
Tags: Health, UK, Science, Israel, US, Trends, South Africa, United Kingdom, Healthcare, Astrazeneca, Novartis, Pfizer, Vaccine, Reuters, Johnson Johnson, Shi

Experts feared India's farming protests would be COVID superspreader events. Poverty, misinformation and a younger population may explain why cases plummeted instead.

Indian Youth Congress (IYC) workers shout slogans during a protest against the new agricultural laws, the rise of unemployment and price rise of goods and services, in New Delhi on India, on February 9 Imtiyaz Khan/Anadolu Agency via Getty Images Mass gatherings such as the farmers' protests didn't become the superspreader events experts feared. COVID cases have steadily fallen, raising hopes the country is close to achieving herd immunity. One expert says misinformation may have been an "...
Tags: Asia, UK, Science, India, America, Trends, NHS, Healthcare, World Health Organization, Vaccine, Delhi, New Delhi, BLM, South Asia, MERS, Kumbh Mela

0 virus deaths reported from 520,000 given the Pfizer vaccine in Israel. Hardly anybody even got sick, suggesting 93% effectiveness.

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP Pfizer's vaccine is working to fight COVID-19, a leading Israeli provider firm said. Maccabi Healthcare Services said that nobody died of 520,000 people who got two doses of the shot. Israel has fully immunized 27% of its population, more than any other country.  Visit the Business section of Insider for more stories. Pfizer-BioNT...
Tags: UK, Science, Israel, Trends, South Africa, Healthcare, Pfizer, Benjamin Netanyahu, Reuters, Tel Aviv Israel, Times of Israel, Johns Hopkins University, Maccabi, Moderna, Sebastian Scheiner, Maccabi Healthcare Services

About 1 in 10 Americans have received at least one dose of coronavirus vaccine

Medical staff prepare to administer COVID-19 vaccines at Northern Navajo Medical Center on December 15, 2020 in Shiprock, New Mexico. Medical staff at the Northern Navajo Medical Center are among the first in the Navajo Nation to receive their Pfizer-BioNTech vaccinations today. Micah Garen/Getty Images Roughly one out of every 10 Americans has received a dose of a COVID-19 vaccine, according to the CDC. Roughly 3% of Americans have been fully inoculated. At the current pace, half of the U...
Tags: Europe, Science, Cdc, US, Trends, Joe Biden, United States, New York Times, Healthcare, Food And Drug Administration, Astrazeneca, Pfizer, Vaccine, Biden, Charles Davis, Johnson & Johnson

Fecal transplants, made up of poop and microbes, are being touted as a promising new treatment for skin cancer patients

Fecal transplants, which are made up of poop and microbes, could be used to help those suffering due to melanoma. AP Fecal transplants, which are made up of poop and microbes, could be used to tackle melanoma. The procedure involves transplanting healthy poop into the gut of a skin cancer patient. A study suggests that these transplants could help patients respond better to immunotherapy. Visit the Business section of Insider for more stories. Fecal transplants are being touted as a promis...
Tags: Science, Cancer, Trends, Healthcare, News UK, Dallas, Poop, Melanoma, Shark Tank, Skin Cancer, Stool, Cancer Immunotherapy, Cancer Prevention, UK Weekend, Joshua Zitser, AP Fecal

The US paid Deloitte $44 million for a vaccine appointment system laden with glitches. Some states are scrambling for an alternative.

ICU nurse Megan Tschacher shows her vaccination card at UC Health Poudre Valley Hospital in Fort Collins, Colorado, on December 14, 2020. Helen H. Richardson/MediaNews Group/The Denver Post/Getty Images The CDC gave Deloitte $44 million as a federal contractor to build a website for vaccine appointments. Most states chose not to use the tool due to concerns about its performance, but nine states opted in. Several health officials from those states say they're experiencing technical glitche...
Tags: Apple, Google, Science, News, Mississippi, California, Cdc, Virginia, US, West Virginia, Trends, Bloomberg, New Hampshire, Maine, Healthcare, Pfizer

Americans will soon have access to 9 at-home COVID-19 tests. Here's how to get them and use them.

Ellume and Abbott Laboratories expect to deliver millions of at-home COVID-19 tests in 2021. Ellume, Jeffrey Rosenthal, Andrea Michelson Six companies are joining the effort to make home COVID-19 testing widely available. The White House plans to boost production of 60 million home tests by summer 2021. Lucira Health, Ellume, and Abbott Laboratories have already been authorized to produce at-home tests. Visit Business Insider's homepage for more stories. The White House COVID-19 Response T...
Tags: Science, Australia, White House, US, Trends, Healthcare, Cvs, Abbott, Abbott Laboratories, Parsons, EUA, Brown University School of Public Health, Ashish Jha, Jeffrey Rosenthal, Coronavirus, COVID